Order Article Reprints

Orea-Soufi A, Castillo-Lluva S, Salvador-Tormo N, Martín-Cabrera P, Recuero S, Gabicagogeascoa E, Moreno-Valladares M, Mendiburu-Eliçabe M, Blanco-Gómez A, Ramos-Pittol JM, et al. The Pseudokinase TRIB3 Negatively Regulates the HER2 Receptor Pathway and Is a Biomarker of Good Prognosis in Luminal Breast Cancer. Cancers. 2021; 13(21):5307. https://doi.org/10.3390/cancers13215307

Orea-Soufi, Alba, Sonia Castillo-Lluva, Nélida Salvador-Tormo, Paola Martín-Cabrera, Silvia Recuero, Estíbaliz Gabicagogeascoa, Manuel Moreno-Valladares, Marina Mendiburu-Eliçabe, Adrián Blanco-Gómez, José Miguel Ramos-Pittol, and et al. 2021. "The Pseudokinase TRIB3 Negatively Regulates the HER2 Receptor Pathway and Is a Biomarker of Good Prognosis in Luminal Breast Cancer" Cancers 13, no. 21: 5307. https://doi.org/10.3390/cancers13215307

Orea-Soufi, A., Castillo-Lluva, S., Salvador-Tormo, N., Martín-Cabrera, P., Recuero, S., Gabicagogeascoa, E., Moreno-Valladares, M., Mendiburu-Eliçabe, M., Blanco-Gómez, A., Ramos-Pittol, J. M., García-Taboada, E., Ocaña, A., Cimas, F. J., Matheu, A., Álvarez-López, I., Velasco, G., & Lorente, M. (2021). The Pseudokinase TRIB3 Negatively Regulates the HER2 Receptor Pathway and Is a Biomarker of Good Prognosis in Luminal Breast Cancer. Cancers, 13(21), 5307. https://doi.org/10.3390/cancers13215307